MediBeacon

United States
Estherwood, Louisiana, United States, 63132

Company profile

MediBeacon company profile

MediBeacon is an optical diagnostic company providing clinicians with critical information that improve patient care. Its mission is to commercialize biocompatible optical diagnostic agents for physiological monitoring, surgical guidance, and imaging of pathological diseases in the human population. Several product concepts in these areas are contained in the MediBeacon Intellectual Property (IP) portfolio. The product pipeline includes real-time kidney function monitoring, a huge leap forward in the world of nephrology. The clinical history and road to FDA and European approvals on this component of the MediBeacon pipeline as well as other developments related to the platform of fluorescent agents and their potential clinical application.

Business identity

Contact email
[email protected]
Phone number
(314) 269-5808
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2011-01-01, Year

Headquarters

Postal code
63132
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
10
Total equity funding
$70.2M
Last funding
Convertible Note / $8.1M / 2022-07-08
Last equity funding
Series Unknown / $34.3M
Investors
6
Lead investors
3
Founders
2
Articles
42

Founders and investors

Founders

Richard DorshowSteve Hanley

Lead investors

InnovateMissouri Technology CorporationPansend Life Sciences, LLC

Investors

BioGeneratorInnovateJump CapitalMissouri Technology CorporationPansend Life Sciences, LLC